Crossmark

Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020

Crossref DOI link: https://doi.org/10.1007/s11096-021-01330-2

Published Online: 2021-09-26

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alsuhibani, Abdulrahman http://orcid.org/0000-0003-4852-1166
Alrasheed, Marwan

Gari, Musaab

Hincapie, Ana L.

Guo, Jeff Jianfei
License Information

Text and Data Mining valid from 2021-09-26

Version of Record valid from 2021-09-26
More Information

Article History

Received: 21 June 2021

Accepted: 14 September 2021

First Online: 26 September 2021

Conflicts of interest

: The authors have no commercial associations that might be a conflict of interest concerning this article.

Document is current

Any future updates will be listed below